Cargando…
Erratum to: An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4937550/ https://www.ncbi.nlm.nih.gov/pubmed/27387831 http://dx.doi.org/10.1186/s13023-016-0463-6 |
| _version_ | 1782441726381654016 |
|---|---|
| author | Attarian, Shahram Vallat, Jean-Michel Magy, Laurent Funalot, Benoît Gonnaud, Pierre-Marie Lacour, Arnaud Péréon, Yann Dubourg, Odile Pouget, Jean Micallef, Joëlle Franques, Jérôme Lefebvre, Marie-Noëlle Ghorab, Karima Al-Moussawi, Mahmoud Tiffreau, Vincent Preudhomme, Marguerite Magot, Armelle Leclair-Visonneau, Laurène Stojkovic, Tanya Bossi, Laura Lehert, Philippe Gilbert, Walter Bertrand, Viviane Mandel, Jonas Milet, Aude Hajj, Rodolphe Boudiaf, Lamia Scart-Grès, Catherine Nabirotchkin, Serguei Guedj, Mickael Chumakov, Ilya Cohen, Daniel |
| author_facet | Attarian, Shahram Vallat, Jean-Michel Magy, Laurent Funalot, Benoît Gonnaud, Pierre-Marie Lacour, Arnaud Péréon, Yann Dubourg, Odile Pouget, Jean Micallef, Joëlle Franques, Jérôme Lefebvre, Marie-Noëlle Ghorab, Karima Al-Moussawi, Mahmoud Tiffreau, Vincent Preudhomme, Marguerite Magot, Armelle Leclair-Visonneau, Laurène Stojkovic, Tanya Bossi, Laura Lehert, Philippe Gilbert, Walter Bertrand, Viviane Mandel, Jonas Milet, Aude Hajj, Rodolphe Boudiaf, Lamia Scart-Grès, Catherine Nabirotchkin, Serguei Guedj, Mickael Chumakov, Ilya Cohen, Daniel |
| author_sort | Attarian, Shahram |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4937550 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2016 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-49375502016-07-09 Erratum to: An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A Attarian, Shahram Vallat, Jean-Michel Magy, Laurent Funalot, Benoît Gonnaud, Pierre-Marie Lacour, Arnaud Péréon, Yann Dubourg, Odile Pouget, Jean Micallef, Joëlle Franques, Jérôme Lefebvre, Marie-Noëlle Ghorab, Karima Al-Moussawi, Mahmoud Tiffreau, Vincent Preudhomme, Marguerite Magot, Armelle Leclair-Visonneau, Laurène Stojkovic, Tanya Bossi, Laura Lehert, Philippe Gilbert, Walter Bertrand, Viviane Mandel, Jonas Milet, Aude Hajj, Rodolphe Boudiaf, Lamia Scart-Grès, Catherine Nabirotchkin, Serguei Guedj, Mickael Chumakov, Ilya Cohen, Daniel Orphanet J Rare Dis Erratum BioMed Central 2016-07-07 /pmc/articles/PMC4937550/ /pubmed/27387831 http://dx.doi.org/10.1186/s13023-016-0463-6 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Erratum Attarian, Shahram Vallat, Jean-Michel Magy, Laurent Funalot, Benoît Gonnaud, Pierre-Marie Lacour, Arnaud Péréon, Yann Dubourg, Odile Pouget, Jean Micallef, Joëlle Franques, Jérôme Lefebvre, Marie-Noëlle Ghorab, Karima Al-Moussawi, Mahmoud Tiffreau, Vincent Preudhomme, Marguerite Magot, Armelle Leclair-Visonneau, Laurène Stojkovic, Tanya Bossi, Laura Lehert, Philippe Gilbert, Walter Bertrand, Viviane Mandel, Jonas Milet, Aude Hajj, Rodolphe Boudiaf, Lamia Scart-Grès, Catherine Nabirotchkin, Serguei Guedj, Mickael Chumakov, Ilya Cohen, Daniel Erratum to: An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A |
| title | Erratum to: An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A |
| title_full | Erratum to: An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A |
| title_fullStr | Erratum to: An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A |
| title_full_unstemmed | Erratum to: An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A |
| title_short | Erratum to: An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A |
| title_sort | erratum to: an exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (pxt3003) in patients with charcot-marie-tooth disease type 1a |
| topic | Erratum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4937550/ https://www.ncbi.nlm.nih.gov/pubmed/27387831 http://dx.doi.org/10.1186/s13023-016-0463-6 |
| work_keys_str_mv | AT attarianshahram erratumtoanexploratoryrandomiseddoubleblindandplacebocontrolledphase2studyofacombinationofbaclofennaltrexoneandsorbitolpxt3003inpatientswithcharcotmarietoothdiseasetype1a AT vallatjeanmichel erratumtoanexploratoryrandomiseddoubleblindandplacebocontrolledphase2studyofacombinationofbaclofennaltrexoneandsorbitolpxt3003inpatientswithcharcotmarietoothdiseasetype1a AT magylaurent erratumtoanexploratoryrandomiseddoubleblindandplacebocontrolledphase2studyofacombinationofbaclofennaltrexoneandsorbitolpxt3003inpatientswithcharcotmarietoothdiseasetype1a AT funalotbenoit erratumtoanexploratoryrandomiseddoubleblindandplacebocontrolledphase2studyofacombinationofbaclofennaltrexoneandsorbitolpxt3003inpatientswithcharcotmarietoothdiseasetype1a AT gonnaudpierremarie erratumtoanexploratoryrandomiseddoubleblindandplacebocontrolledphase2studyofacombinationofbaclofennaltrexoneandsorbitolpxt3003inpatientswithcharcotmarietoothdiseasetype1a AT lacourarnaud erratumtoanexploratoryrandomiseddoubleblindandplacebocontrolledphase2studyofacombinationofbaclofennaltrexoneandsorbitolpxt3003inpatientswithcharcotmarietoothdiseasetype1a AT pereonyann erratumtoanexploratoryrandomiseddoubleblindandplacebocontrolledphase2studyofacombinationofbaclofennaltrexoneandsorbitolpxt3003inpatientswithcharcotmarietoothdiseasetype1a AT dubourgodile erratumtoanexploratoryrandomiseddoubleblindandplacebocontrolledphase2studyofacombinationofbaclofennaltrexoneandsorbitolpxt3003inpatientswithcharcotmarietoothdiseasetype1a AT pougetjean erratumtoanexploratoryrandomiseddoubleblindandplacebocontrolledphase2studyofacombinationofbaclofennaltrexoneandsorbitolpxt3003inpatientswithcharcotmarietoothdiseasetype1a AT micallefjoelle erratumtoanexploratoryrandomiseddoubleblindandplacebocontrolledphase2studyofacombinationofbaclofennaltrexoneandsorbitolpxt3003inpatientswithcharcotmarietoothdiseasetype1a AT franquesjerome erratumtoanexploratoryrandomiseddoubleblindandplacebocontrolledphase2studyofacombinationofbaclofennaltrexoneandsorbitolpxt3003inpatientswithcharcotmarietoothdiseasetype1a AT lefebvremarienoelle erratumtoanexploratoryrandomiseddoubleblindandplacebocontrolledphase2studyofacombinationofbaclofennaltrexoneandsorbitolpxt3003inpatientswithcharcotmarietoothdiseasetype1a AT ghorabkarima erratumtoanexploratoryrandomiseddoubleblindandplacebocontrolledphase2studyofacombinationofbaclofennaltrexoneandsorbitolpxt3003inpatientswithcharcotmarietoothdiseasetype1a AT almoussawimahmoud erratumtoanexploratoryrandomiseddoubleblindandplacebocontrolledphase2studyofacombinationofbaclofennaltrexoneandsorbitolpxt3003inpatientswithcharcotmarietoothdiseasetype1a AT tiffreauvincent erratumtoanexploratoryrandomiseddoubleblindandplacebocontrolledphase2studyofacombinationofbaclofennaltrexoneandsorbitolpxt3003inpatientswithcharcotmarietoothdiseasetype1a AT preudhommemarguerite erratumtoanexploratoryrandomiseddoubleblindandplacebocontrolledphase2studyofacombinationofbaclofennaltrexoneandsorbitolpxt3003inpatientswithcharcotmarietoothdiseasetype1a AT magotarmelle erratumtoanexploratoryrandomiseddoubleblindandplacebocontrolledphase2studyofacombinationofbaclofennaltrexoneandsorbitolpxt3003inpatientswithcharcotmarietoothdiseasetype1a AT leclairvisonneaulaurene erratumtoanexploratoryrandomiseddoubleblindandplacebocontrolledphase2studyofacombinationofbaclofennaltrexoneandsorbitolpxt3003inpatientswithcharcotmarietoothdiseasetype1a AT stojkovictanya erratumtoanexploratoryrandomiseddoubleblindandplacebocontrolledphase2studyofacombinationofbaclofennaltrexoneandsorbitolpxt3003inpatientswithcharcotmarietoothdiseasetype1a AT bossilaura erratumtoanexploratoryrandomiseddoubleblindandplacebocontrolledphase2studyofacombinationofbaclofennaltrexoneandsorbitolpxt3003inpatientswithcharcotmarietoothdiseasetype1a AT lehertphilippe erratumtoanexploratoryrandomiseddoubleblindandplacebocontrolledphase2studyofacombinationofbaclofennaltrexoneandsorbitolpxt3003inpatientswithcharcotmarietoothdiseasetype1a AT gilbertwalter erratumtoanexploratoryrandomiseddoubleblindandplacebocontrolledphase2studyofacombinationofbaclofennaltrexoneandsorbitolpxt3003inpatientswithcharcotmarietoothdiseasetype1a AT bertrandviviane erratumtoanexploratoryrandomiseddoubleblindandplacebocontrolledphase2studyofacombinationofbaclofennaltrexoneandsorbitolpxt3003inpatientswithcharcotmarietoothdiseasetype1a AT mandeljonas erratumtoanexploratoryrandomiseddoubleblindandplacebocontrolledphase2studyofacombinationofbaclofennaltrexoneandsorbitolpxt3003inpatientswithcharcotmarietoothdiseasetype1a AT miletaude erratumtoanexploratoryrandomiseddoubleblindandplacebocontrolledphase2studyofacombinationofbaclofennaltrexoneandsorbitolpxt3003inpatientswithcharcotmarietoothdiseasetype1a AT hajjrodolphe erratumtoanexploratoryrandomiseddoubleblindandplacebocontrolledphase2studyofacombinationofbaclofennaltrexoneandsorbitolpxt3003inpatientswithcharcotmarietoothdiseasetype1a AT boudiaflamia erratumtoanexploratoryrandomiseddoubleblindandplacebocontrolledphase2studyofacombinationofbaclofennaltrexoneandsorbitolpxt3003inpatientswithcharcotmarietoothdiseasetype1a AT scartgrescatherine erratumtoanexploratoryrandomiseddoubleblindandplacebocontrolledphase2studyofacombinationofbaclofennaltrexoneandsorbitolpxt3003inpatientswithcharcotmarietoothdiseasetype1a AT nabirotchkinserguei erratumtoanexploratoryrandomiseddoubleblindandplacebocontrolledphase2studyofacombinationofbaclofennaltrexoneandsorbitolpxt3003inpatientswithcharcotmarietoothdiseasetype1a AT guedjmickael erratumtoanexploratoryrandomiseddoubleblindandplacebocontrolledphase2studyofacombinationofbaclofennaltrexoneandsorbitolpxt3003inpatientswithcharcotmarietoothdiseasetype1a AT chumakovilya erratumtoanexploratoryrandomiseddoubleblindandplacebocontrolledphase2studyofacombinationofbaclofennaltrexoneandsorbitolpxt3003inpatientswithcharcotmarietoothdiseasetype1a AT cohendaniel erratumtoanexploratoryrandomiseddoubleblindandplacebocontrolledphase2studyofacombinationofbaclofennaltrexoneandsorbitolpxt3003inpatientswithcharcotmarietoothdiseasetype1a |